
Marianne P. Allen
Examiner (ID: 17617, Phone: (571)272-0712 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1818, 1812, 1645, 1805, 1631, 1647 |
| Total Applications | 2168 |
| Issued Applications | 1046 |
| Pending Applications | 251 |
| Abandoned Applications | 885 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6939060
[patent_doc_number] => 20050112623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Bio-cell chip'
[patent_app_type] => utility
[patent_app_number] => 10/920054
[patent_app_country] => US
[patent_app_date] => 2004-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2168
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112623.pdf
[firstpage_image] =>[orig_patent_app_number] => 10920054
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/920054 | Bio-cell chip | Aug 16, 2004 | Abandoned |
Array
(
[id] => 7145221
[patent_doc_number] => 20050119165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Vascular endothelial growth factor dimers'
[patent_app_type] => utility
[patent_app_number] => 10/917577
[patent_app_country] => US
[patent_app_date] => 2004-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21814
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20050119165.pdf
[firstpage_image] =>[orig_patent_app_number] => 10917577
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/917577 | Vascular endothelial growth factor dimers | Aug 12, 2004 | Abandoned |
Array
(
[id] => 4960524
[patent_doc_number] => 20080274949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'Formulation of Albumin-Free Erythropoietin'
[patent_app_type] => utility
[patent_app_number] => 10/567475
[patent_app_country] => US
[patent_app_date] => 2004-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4376
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274949.pdf
[firstpage_image] =>[orig_patent_app_number] => 10567475
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/567475 | Formulation of Albumin-Free Erythropoietin | Jul 26, 2004 | Abandoned |
Array
(
[id] => 6991452
[patent_doc_number] => 20050090489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Use of a substance which binds to the peripheral benzodiazepine receptor in the treatment of cutaneous stress'
[patent_app_type] => utility
[patent_app_number] => 10/898793
[patent_app_country] => US
[patent_app_date] => 2004-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4958
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090489.pdf
[firstpage_image] =>[orig_patent_app_number] => 10898793
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/898793 | Use of a substance which binds to the peripheral benzodiazepine receptor in the treatment of cutaneous stress | Jul 25, 2004 | Abandoned |
Array
(
[id] => 7233914
[patent_doc_number] => 20050079549
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Methods for modeling GPCRs and for producing ligand blocking and receptor activating antibodies for same'
[patent_app_type] => utility
[patent_app_number] => 10/897170
[patent_app_country] => US
[patent_app_date] => 2004-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9298
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20050079549.pdf
[firstpage_image] =>[orig_patent_app_number] => 10897170
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/897170 | Methods for modeling GPCRs and for producing ligand blocking and receptor activating antibodies for same | Jul 21, 2004 | Abandoned |
Array
(
[id] => 4971954
[patent_doc_number] => 20070111957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-17
[patent_title] => 'Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/565418
[patent_app_country] => US
[patent_app_date] => 2004-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13127
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20070111957.pdf
[firstpage_image] =>[orig_patent_app_number] => 10565418
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/565418 | Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof | Jul 19, 2004 | Abandoned |
Array
(
[id] => 8955701
[patent_doc_number] => 08501473
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-06
[patent_title] => 'Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/564769
[patent_app_country] => US
[patent_app_date] => 2004-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 18465
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10564769
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/564769 | Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome | Jul 14, 2004 | Issued |
Array
(
[id] => 7206174
[patent_doc_number] => 20050043237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use'
[patent_app_type] => utility
[patent_app_number] => 10/892981
[patent_app_country] => US
[patent_app_date] => 2004-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 18273
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043237.pdf
[firstpage_image] =>[orig_patent_app_number] => 10892981
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/892981 | Pituitary adenylate cyclase activating peptide (PACAP) receptor 3 (R3) agonists and their pharmacological methods of use | Jul 14, 2004 | Issued |
Array
(
[id] => 5739234
[patent_doc_number] => 20060009625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Method for purifying a protein of the cystine-knot superfamily'
[patent_app_type] => utility
[patent_app_number] => 10/887106
[patent_app_country] => US
[patent_app_date] => 2004-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10333
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009625.pdf
[firstpage_image] =>[orig_patent_app_number] => 10887106
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/887106 | Method for purifying a protein of the cystine-knot superfamily | Jul 7, 2004 | Issued |
Array
(
[id] => 168410
[patent_doc_number] => 07666841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-23
[patent_title] => 'Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1)'
[patent_app_type] => utility
[patent_app_number] => 10/569012
[patent_app_country] => US
[patent_app_date] => 2004-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 7776
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/666/07666841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10569012
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/569012 | Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1) | Jul 4, 2004 | Issued |
Array
(
[id] => 359825
[patent_doc_number] => 07485704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-03
[patent_title] => 'Reducing protein A leaching during protein A affinity chromatography'
[patent_app_type] => utility
[patent_app_number] => 10/877532
[patent_app_country] => US
[patent_app_date] => 2004-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 14675
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/485/07485704.pdf
[firstpage_image] =>[orig_patent_app_number] => 10877532
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/877532 | Reducing protein A leaching during protein A affinity chromatography | Jun 23, 2004 | Issued |
Array
(
[id] => 7206162
[patent_doc_number] => 20050043235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Use of VEGF-C or VEGF-D in reconstructive surgery'
[patent_app_type] => utility
[patent_app_number] => 10/868549
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 28460
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043235.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868549
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868549 | Use of VEGF-C or VEGF-D in reconstructive surgery | Jun 13, 2004 | Abandoned |
Array
(
[id] => 830276
[patent_doc_number] => 07399830
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-15
[patent_title] => 'Synaptic activation protein compositions and method'
[patent_app_type] => utility
[patent_app_number] => 10/866256
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 35
[patent_no_of_words] => 11280
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/399/07399830.pdf
[firstpage_image] =>[orig_patent_app_number] => 10866256
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/866256 | Synaptic activation protein compositions and method | Jun 9, 2004 | Issued |
Array
(
[id] => 7275590
[patent_doc_number] => 20040235041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Nucleic acids containing single nucleotide polymorphisms and methods of use thereof'
[patent_app_type] => new
[patent_app_number] => 10/865478
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20707
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235041.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865478
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865478 | Nucleic acids containing single nucleotide polymorphisms and methods of use thereof | Jun 9, 2004 | Abandoned |
Array
(
[id] => 7276289
[patent_doc_number] => 20040235740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Polypeptides homologous to VEGF and BMPI'
[patent_app_type] => new
[patent_app_number] => 10/863133
[patent_app_country] => US
[patent_app_date] => 2004-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 38691
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235740.pdf
[firstpage_image] =>[orig_patent_app_number] => 10863133
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/863133 | Polypeptides homologous to VEGF and BMPI | Jun 7, 2004 | Abandoned |
Array
(
[id] => 5794254
[patent_doc_number] => 20060014935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Fas ligand derived polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/861934
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 40469
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10861934
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/861934 | FAS ligand derived polypeptides | Jun 6, 2004 | Issued |
Array
(
[id] => 5794254
[patent_doc_number] => 20060014935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Fas ligand derived polypeptides'
[patent_app_type] => utility
[patent_app_number] => 10/861934
[patent_app_country] => US
[patent_app_date] => 2004-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 40469
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10861934
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/861934 | FAS ligand derived polypeptides | Jun 6, 2004 | Issued |
Array
(
[id] => 6971721
[patent_doc_number] => 20050037431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-17
[patent_title] => 'Methods and compositions for modulating HGF/Met'
[patent_app_type] => utility
[patent_app_number] => 10/862192
[patent_app_country] => US
[patent_app_date] => 2004-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 29219
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20050037431.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862192
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862192 | Methods and compositions for modulating HGF/Met | Jun 3, 2004 | Abandoned |
Array
(
[id] => 7318969
[patent_doc_number] => 20040224915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'High affinity vascular endothelial growth factor(VEGF) receptor nucleic acid ligands and inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/862084
[patent_app_country] => US
[patent_app_date] => 2004-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12377
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20040224915.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862084
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862084 | High affinity vascular endothelial growth factor(VEGF) receptor nucleic acid ligands and inhibitors | Jun 3, 2004 | Abandoned |
Array
(
[id] => 7375149
[patent_doc_number] => 20040219640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Polypeptides homologous to VEGFand BMPI'
[patent_app_type] => new
[patent_app_number] => 10/862134
[patent_app_country] => US
[patent_app_date] => 2004-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 38672
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219640.pdf
[firstpage_image] =>[orig_patent_app_number] => 10862134
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/862134 | Polypeptides homologous to VEGF and BMP1 | Jun 3, 2004 | Issued |